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ABSTRACT
PATIENT SEX AND PHYSICIAN ADHERENCE TO TREATMENT GUIDELINES
FOR NON-PURULENT CELLULITIS
MAY 2019
REBECCA F. GOLDBERG, B.S., UNIVERSITY OF MASSACHUSETTS, AMHERST,
M.S., UNIVERSITY OF MASSACHUSETTS, AMHERST
Directed by: Dr. Brian Whitcomb
In 2015, participating US Emergency Departments (EDs) reported approximately 2.8
million visits related to skin and soft tissue infections (SSTIs). Studies indicate that there
may be disparities by patient sex in physician treatment guideline adherence rates as a
result of a gender bias during physician-patient interactions; however, only two
epidemiologic studies have investigated the role of patient sex in guideline adherence
rates for SSTIs. These prior studies were limited in size and covariate assessment. Thus,
the magnitude and direction of the effect of patient sex is uncertain, warranting further
research. Therefore, we conducted a large prospective study to elucidate the role that
patient sex plays in guideline adherence rates among physicians for non-purulent
cellulitis at two UMass Memorial Health Care Group EDs in 2017. Data on treatment and
sex was abstracted from electronic medical records. Compliance with treatment
guidelines was based on 2014 Infectious Disease Society of America (IDSA) guidelines.
Adjusted multinomial regressions indicated that female patient sex was associated with
lower prevalence of overtreatment (POR=0.72, 95%CI: 0.57-0.92). In contrast, female
physician sex was significantly associated with higher prevalence of overtreatment
(POR=1.48, 95%CI: 1.16-1.87), but did not affect the relationship of patient sex with
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overtreatment (P-interaction=0.80). Awareness of differential treatment by patient sex
may improve physician adherence to guidelines. This study contributes to a growing
body of literature elucidating the role of sex in medical decision making and is the first to
account for both patient and physician sex as well as relevant covariates in studies
regarding cellulitis treatment.
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CHAPTER I
INTRODUCTION
Non-purulent cellulitis is a common type of skin and soft tissue infection (SSTI)
that is characterized by redness, warmth, and tenderness.1 In 2015, the National Hospital
Ambulatory Medical Care Survey, including data from 267 United States (US)
Emergency Departments (EDs), reported approximately 2.8 million visits related to
cellulitis and abscess.2 Among females ages 15-64, 1.007 million visits to the ED were
made for cellulitis and abscess as compared to 1.049 million visits among males.3 Studies
have indicated that treatment adherence rates for SSTIs are about 40%.4,5
Cellulitis can resolve quickly if treated with antibiotics early, but if left untreated,
treated late, or treated with the incorrect antibiotics, the infection can spread and in rare
cases become fatal.3 Inappropriate treatment, or treatment that does not adhere to
guidelines, can lead to the overuse of antibiotics and the development of bacterial
resistance.4 Overuse of stronger antibiotics can result in antibiotic resistance or negative
side effects, while prescription of antibiotics that are too weak may not treat the
infection.6 The treatment course for cellulitis is determined by the Infectious Disease
Society of America (IDSA)6 which denotes guidelines that rank infections as mild,
moderate, and severe, with corresponding treatment protocols. These criteria use
objective signs and symptoms such as systemic signs of infection, evidence of MRSA,
IVDU, history of infection, or treatment for malignancy to make treatment decisions.6
The protocols emphasize the importance of timely assessment and antibiotic
administration.6
The risk factors for physicians failing to adhere to treatment guidelines include
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patient age4; a lack of awareness of specific guideline-recommendations7; tension
between adhering to guidelines and the desire to individualize patient care7; physician
skepticism of certain guideline- recommendations7; patient comorbidities5; need for
antibiotic administration4,5; purulence (which requires alternative treatment protocols)5,6;
and sex.4,5 Sex and race are known risk factors for treatment disparities for other diseases,
such as acute coronary syndromes8 or Non-Hodgkin’s Lymphoma.9 Therefore, we
evaluated the relationship between patient sex and physician guideline adherence for
cellulitis. Physician sex can contribute to differences in physician-patient interactions
through a gender bias during doctor-patient interactions.10,11 Three psychological
mechanisms have been proposed to explain this bias: 1) gender stereotypes, 2) gender
concordant or discordant pairings, and 3) approachability.10 Physicians may apply their
own biases regarding certain patient sexes to treatment protocols, which could impact
guideline adherence, despite objective measures of the infection. In addition, patients
who feel less comfortable with their physician may provide less information (e.g. medical
history) during visits. These poor interactions could translate to worse care and thus a
lack of guideline adherence among physicians.
Eight studies in the United States from the past five years have evaluated the
association between patient sex and treatment guideline adherence among physicians for
a variety of diseases4,5,12-16 or antibiotic administration,17 a core tenet of infection
treatment guidelines.6 Only two studies evaluated treatment guideline adherence for skin
and soft tissue infections, including cellulitis.4,5 Most of these studies, regardless of
exposure and disease, demonstrate a significant difference in guideline adherence
depending on patient sex.4,5,13,15-17 Two prior studies published in recent years examined
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the specific relationship between patient sex and guideline adherence for non-purulent
cellulitis,4,5 but these were limited in sample size, included purulent cases, and did not
adjust for covariates.
This study will adjust for known risk factors, such as age, and other potential
confounders including race, comorbidities, and IVDU in the analysis. There is conflicting
information regarding the direction of the SSTI treatment disparity between male and
female patient.4,5 Despite this discrepancy, the overall literature indicates a negative
association between female patient sex and physician guideline adherence. This study
will be significant because it will contribute to a growing body of literature elucidating
the role of sex in medical decision making, and it will be the first, to our knowledge, to
evaluate this association with a large sample size and multivariable adjustment in relation
to non-purulent cellulitis treatment.
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CHAPTER II
METHODS
A. Study Design
This study includes data from a parent study aimed at determining the
effectiveness of a treatment algorithm intervention based on IDSA guidelines in
improving physician adherence to guidelines. Physicians were provided educational
materials and personalized data regarding prior adherence rates with the goal of
improving physician adherence rates over time. The intervention was implemented in
June 2017, so visits prior to this date were considered pre-intervention and those after
were considered post-intervention. Data for both studies included records of patients that
presented to two EDs belonging to the UMass Memorial Health Care Group (UMMHC)
between January 1 and December 31, 2017. One of the selected EDs is an urban tertiary
care teaching hospital and the other is a community site, both serving a diverse
population in Worcester, MA. Eligible individuals consisted of those over 18 years old
who were diagnosed with non-purulent cellulitis in the ED during the 2017 calendar year.
Subjects were ascertained by searching for cellulitis diagnoses among all electronic
medical records (EMRs). Exclusion criteria consisted of: 1) incision and drainage with
expression of purulent material, 2) incomplete medical record or 3) a repeat visit within
four weeks for treatment of the same SSTI. Individuals could be included multiple times
for different SSTIs. A total of 1,360 individuals met the criteria for enrollment. Guideline
adherence of prescribed treatment to standard guidelines was defined as compliance with
treatment guidelines published by the 2014 Infectious Disease Society of America
(IDSA).6
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B. Exposure Assessment
EMRs provided information on participant sex. Sex is a dichotomous variable
defined as either male or female. Sex was defined by patients while filling out
demographic surveys for the hospital and was confirmed during ED visits by nurses.

C. Outcome Assessment
EMRs were also consulted for description of infection and treatment course.
Guideline adherence was assessed using diagnostic criteria defined by the 2014
Infectious Disease Society of America.6 To determine if treatment outcome was correctly
assigned, two physicians assigned scores and compared them for agreement. If there was
a discrepancy, a third physician was consulted to make an evaluation. Following the
IDSA guidelines, patients were assigned a severity score for their non-purulent SSTI
infection at the following levels: mild, moderate, or severe.6 These protocols involve
different classes of antibiotics depending on the severity.6 Based on this classification, an
anticipated treatment course was determined using corresponding treatment protocols
from the IDSA for mild, moderate, and severe cases.6 The observed antibiotic course was
similarly classified using these same levels. Finally, the anticipated and observed
antibiotic courses were compared. A three-level outcome variable was created as follows:
those with higher anticipated than observed antibiotic courses were considered
undertreated; those with lower anticipated than observed were considered overtreated;
and those with scores that matched were considered adherent. A two-level outcome
classification was also assigned to reflect whether treatment was adherent to guidelines or
not adherent (including undertreated and overtreated). Though variables collected from
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EMRs regarding inpatient or ED care, such as treatment course, are more complex than
those from outpatient care, and are more susceptible to inaccuracies,18 this multiplephysician review system of EMRs was conducted to maximize the validity of this
assessment.

D. Covariate Assessment
Covariates were selected a priori due to demonstrated relationships in the
literature. Data for these covariates were gathered from EMRs. These include age,4
IVDU,5 race,8 and Charlson Comorbidity Index (CCI), a scale that predicts mortality
given medical history.4 Medical history was captured from the EMR by trained research
assistants and used to calculate CCI. CCI Score was converted into a categorical variable
(Mild: ≤2, Moderate: 3-4, Severe: 5+) as established by the Index literature.19 Physician
sex was also taken from the EMR using the name of the prescribing physician. If no
prescribing physician was included in the EMR, the attending physician was used to
classify physician sex.

E. Statistical Analysis
Bivariate analyses cross-tabulated both sex and covariates with treatment
adherence level. Covariates include age category, CCI Score, race/ethnicity, history of
IVDU, and physician sex. All covariates are categorical variables, and therefore were
analyzed using chi-square tests, or Fisher’s exact test, given small sample sizes, with pvalues reported. Two-sided p-values ≤ 0.05 were considered statistically significant.
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The association between sex and both the two-level and three-level treatment
guideline adherence outcomes were modeled using binomial and multinomial logistic
regression with odds ratios and 95% CI’s reported. Covariates selected a priori were
considered for inclusion in multivariable models. Any covariate that was significantly
associated with the outcome at the 0.10 level was retained; similarly, if inclusion of a
covariate resulted in a change of at least 15% to the coefficient estimate for the primary
exposure (i.e., patient sex or physician sex), it was retained in the model.
The association of prescribing physician sex with guideline adherence was also
investigated in a series of analyses. The association between physician sex and the threelevel outcome was assessed using a multinomial model and adjusted for covariates, as
previously described. In order to evaluate both patient sex and physician sex with regard
to guideline adherence, both physician and patient sex were then included in one model
adjusting for each other. Admittance and IV drug administration were also analyzed as
representations of more aggressive treatment methods that may have been differential by
sex. To account for differences in adherence as a result of an intervention related to a
different study outcome, the adjusted multinomial analyses of both physician and patient
sex were stratified by intervention status. Finally, in order to evaluate physician sex as a
modifier of the association of patient sex with physician guideline adherence, a
multiplicative interaction term was included in models as physician sex*patient sex, and
tested for statistical significance. Similarly, modification of associations of both patient
sex and physician sex with outcomes by the trial intervention were considered; these
were evaluated by inclusion of multiplicative interaction terms, patient sex*intervention
status and physician sex*intervention status, and tested for statistical significance.
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CHAPTER III
RESULTS
A. Study Population Characteristics
The original study population consisted of 1,524 patients diagnosed with a nonpurulent SSTI at one of the two ED sites (Table 1). Of this group, 36 were removed due
to a documented incision and drainage for an abscess and 128 were repeat visits. The
final study sample included 1,360 patients (Table 1). Minimal data was captured to
characterize physicians.
The patient population was 53.9% male with an average age of 50.82 (standard
deviation (SD) = 18.16) (Table 2). The majority of patients was White (75.6%) and seen
at the University campus (54.3%). Individuals were most likely to be discharged after
treatment (69.3%), with fewer admitted (28.5%) or sent to the Clinical Decision Unit
(CDU) (2.2%). Fevers occurred in 17% of patients, and the majority of patients had a
mild CCI Score (Table 2).

B. Patient Sex and Physician Adherence
Bivariate analysis of patient sex and treatment adherence type demonstrated a
significant association (p=0.01). The largest percentage of males were overtreated
(45.43%) while the largest percentage of females were appropriately treated (51.04%).
An analysis of two-level treatment adherence demonstrated that female patient sex is
associated with lower odds of physicians failing to adhere to guidelines after adjusting for
CCI Score, race, and IVDU (POR = 0.75, 95%CI: 0.61-0.94) (Table 3). Other treatment
outcomes such as disposition or IV antibiotic administration were not significantly
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associated with sex (data not shown). Given these results, the three-level outcome and
multinomial regression were used to differentiate between those over- and undertreated.
Chi square analysis of the three-level outcome indicated that patient sex was a significant
predictor of treatment adherence (p=0.01) (Table 4). In the multinomial regression
adjusted for age over 65, CCI Score, race and IVDU, the protective effect was slightly
attenuated though still significant among overtreated female patients (POR=0.72. 95%CI:
0.57-0.91), but not statistically significant among undertreated (POR=0.89, 95%CI: 0.611.29) (Table 4). Among male patients, 45% were overtreated, which is 7% higher than
the percent of women who were overtreated.

C. Patient Sex and Physician Adherence, Stratified by Intervention Status
An adjusted multinomial model of patient sex and treatment adherence was also
stratified by intervention status in order to compare the association between the two time
periods (Table 5). Comparing physician treatment adherence in female patients to that in
male patients, similar results were observed regarding overtreatment for pre- (POR=0.77,
95%CI: 0.55-1.08) and post-intervention (POR=0.67, 95%CI: 0.48-0.93). Point estimates
for undertreatment varied between pre- and post-intervention, but results from adjusted
models were not statistically significant for pre- (POR=1.09, 95%CI: 0.61-1.94) or postintervention (POR=0.78, 95%CI: 0.48-1.29), and the test for interaction was nonsignificant (P-interaction=0.5), supporting no significant difference in the relationship
between pre- and post-intervention periods.
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D. Physician Sex and Physician Adherence, Stratified by Intervention
To explore alternative explanations for these observations, additional sensitivity
analyses were conducted. We first investigated the role that physician sex may have
played as a confounder or effect modifier of the association between patient sex and
physician adherence. We then explored whether the relationships observed for both
patient sex and physician sex were modified by the parent study intervention. In a
multinomial model adjusted for categorical age, CCI Score, race, and IVDU, female
physician sex was significantly associated with higher prevalence of overtreatment
(POR=1.48, 95%CI: 1.16-1.88), but not with undertreatment (Table 4). Analysis
stratified on intervention status was conducted to evaluate the association of physician
sex with adherence separately pre- and post-intervention. In this analysis, higher odds of
overtreatment were observed in both the pre-intervention period (POR=1.79, 95%CI:
1.26-2.55) and post-intervention period (POR=1.28, 95%CI: 0.91-1.79); based on a test
of interaction, these estimates were not statistically significantly different (Pinteraction=0.4) (Table 5). Comparison of estimates from the pre- and post-intervention
periods suggest that implementation of the intervention reduced female physician
overtreatment so that physician sex was not a significant predictor of guideline adherence
in the post-intervention group (p=0.34).

E. Patient Sex and Physician Sex Interaction
Further analyses to test the role of physician sex were conducted in a model that
included both patient sex and physician sex. To address the possibility that adherence
might vary by combinations of physician and patient sex (e.g., concordant vs. discordant
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pairings), models including an interaction term were evaluated. There was no significant
interaction between physician sex and patient sex (P-interaction=0.80), suggesting that
associations of patient sex with treatment adherence were similar regardless of physician
sex (Figure 1). A multinomial model (adjusted for age category, CCI Score, race and
IVDU) that includes physician sex without the interaction term indicated that female
patient sex was significantly protective against overtreatment (POR=0.72, 95%CI: 0.570.92), and female physician sex increased the odds of overtreatment (POR=1.47, 95%CI:
1.16-1.87) (Table 4).
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CHAPTER IV
DISCUSSION
In this study, we observed that treatment guideline adherence varied by patient
sex and physician sex. Analysis of the two-level adherence outcome demonstrated that
female patients were more likely to be treated according to guidelines, which is consistent
in direction with literature concerning SSTI treatment. One prior study by Ezebuenyi et
al. reported that the odds of males being treated according to guidelines as compared to
females was 0.495, or 50.5% reduced odds.5 The stronger association seen in this prior
study could be attributed to the relatively small sample size, which also included many
purulent cases.5 In fact, half of the sample size in the study consisted of purulent
infections, which is independently related to both male sex and physician failure to
adhere to treatment guidelines.4,5 Of note, the direction of association demonstrated in
both our study and the prior by Ezebuenyi et al. is opposite to results shown in literature
for other health issues.13,15,16,17 The cause of this disparity is unclear.
The three-level analysis demonstrated that female patient sex was protective
against overtreatment for cellulitis compared to male patient sex. This result also
indicates that males received more aggressive treatments compared to females. Steps
taken to adjust for possible confounders and effect modifiers did little to change these
findings. This result is consistent with prior literature in this setting, although our
findings did not replicate prior findings of increased risk of undertreatment.4
Physician sex is also known to contribute to differences in physician-patient
interactions,10,11 which could impact guideline adherence. The findings of this study
indicated that female physician sex was associated with decreased odds of adherence to
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guidelines. The association between physician sex and adherence is understudied in
literature; thus, there is little evidence to support or contradict this finding. Prior literature
has indicated that improved physician-patient relationships are associated with female
physicians due to more thorough conversations and amiable actions, which could
manifest as improved treatment and guideline adherence.10,11 Our analysis indicates that
there was no interaction between patient and physician sex, although there is a lack of
literature to compare this finding with regarding the role of interaction in adherence.
This research indicates that differential care by sex remains an issue in healthcare,
though interventions aimed at improving care are effective. As seen in this analysis, the
parent study intervention reduced rates of over- and undertreatment, and uptake of the
intervention was not significantly different among physician or patient sexes. These
findings are significant because they identify more specific disparities in treatment, with
implications for targeted interventions.
This study is part of a larger one involving an intervention aimed at lowering rates
of overtreatment, which contributed to the lowered measures of association seen among
both physician and patient sex after stratification. Physicians, regardless of sex, may be
much more conscious of overtreatment after the intervention, although changes in
adherence after the intervention do not significantly differ by patient sex. In addition,
stratifying the three-level outcome may have resulted in cell sizes that were too small to
accurately represent adherence trends.
A few potential limitations that might impact inferences from the study are of
note. There is the potential for non-differential misclassification of exposure due to the
fact that although sex is patient reported, this sex may not be representative of the sex
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used by the physician in medical decision making. This occurrence is unlikely, and the
impact on our study would be minimal. Related to outcome, the original infection may
have been misclassified due to the withholding of factors relevant to treatment by the
patient or physician, which would not have been captured in the EMR, but this
occurrence is unlikely given rigorous documentation processes required by the EMR.
Therefore, the potential for any misclassification to alter measures of association is
extremely small. There are few scenarios that would have permitted selection or
information bias. Selection was not related to exposure or outcome and, although our
evaluation is subject to the contents of the EMR, for reasons mentioned before, it is
unlikely that patient sex resulted in differences in data collection or judgments regarding
guideline adherence assignment. Despite a very short follow up time, there is also no
concern for temporality, because sex could not have changed at any point during the very
short duration between seeking and receipt of treatment. Confounders were widely
assessed for this study, which supports prior history which did not account for any and
provides information for future studies regarding relevant covariates.4,5
This study was conducted in a setting that is accessible to a diverse population
and investigated a disease for which all individuals are at risk. It is unclear how
generalizable the results of this study are because mechanisms through which a sex-based
differential occurred were unobserved or were not measured in this study.10,11 Because of
lower risk associated with female patient sex, employment of gender stereotypes is
unlikely. There was no significant interaction between patient and physician sex, thus
effects of concordant or discordant pairing are also unlikely. Finally, we were unable to
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evaluate mechanistic factors such as approachability because there was limited data on
physician behavior in the charts.
Physicians within one hospital often have similar practices as a result of being
affiliated with the same association. There may be clustering by hospital type or by
physician. Further research should gather physician-related data and adjust for clustering
effects. It should also gather a wider variety of physician-related factors or include a
larger sample size to allow for further detection of mechanisms or use a different setting.
This research has implications for more tailored interventions aimed at reducing
rates of treatment that does not adhere to guidelines by identifying which populations are
affected by which adherence type. More widespread implementation of interventions
aimed at reducing these disparities could increase guideline adherence and improve
outcomes for patients. In some cases, guideline adherence may not directly correlate with
improved care, especially when provisions of the guidelines conflict with each other and
physicians must weigh multiple factors in making medical judgments. It is also possible
that decisions made regarding the weighing of these factors is not indicated in the EMR,
which would then not be visible to the researchers. Thus, care should be taken when
equating adherence with beneficial care. This investigation also strengthens current
literature that did not adjust for covariates by demonstrating that adjusting for covariates
did not impact point estimates. Finally, these relationships warrant further research
because no literature exists to our knowledge regarding the role of physician sex and
cellulitis treatment or analysis of mechanisms directly impacting adherence for cellulitis
treatment, thus there is limited prior knowledge to which we can compare these results.
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Table 1. Number
in in
Final
Sample;
Cellulitis
Study,
2017.2017.
Table
Numberand
andPercent
Percent
Final
Sample;
Cellulitis
Study,
Original Study Sample

N
1524

(%)
--

Excluded
Incision & Drainage (Purulence)
Repeat Visit

164
36
128

10.8
2.4
8.4

Final Study Sample

1360

89.2
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Table 2. Distribution of Covariates According to Physician Treatment Guideline
Adherence;
Cellulitis
Study,
2017.
Table 2. Distribution
of Covariates
According
to Physician Treatment Guideline Adherence; Cellulitis Study, 2017.
Patient Sex
N=1360
CCI
N= 1360

Age
N=1360

Male
Female

History of IVDU
N= 1360

Disposition
N=1360

Fever
N=1360

Location
N=1360

Physician Sex
N=1357

Adherent
N(%)
316 43.11
320 51.04

Overtreated
N(%)
333 45.43
239 38.12

P-value
0.01

Mild
Moderate
Severe

131
20
1

11.05
14.93
2.5

578
45
13

48.74
33.58
32.5

477
69
26

40.22
51.49
65

0.0003

<65
65+

137
15

13.06
4.82

508
128

48.43
41.16

404
168

38.51
54.02

<0.0001

48.69

18.54

55.29

17.2

<0.0001

Age, Continuous
N=1360
Race/Ethnicity
N= 1345

Undertreated
N (%)
84 11.46
68 10.85

42.86

15.7

White
Non-White

110
40

10.82
12.2

445
184

43.76
56.1

462
104

45.43
31.71

<0.0001

No
Yes

98
54

8.09
36.24

598
38

49.38
25.5

515
57

42.53
38.26

<0.0001

Discharge

145

15.38

565

59.92

233

24.71

Admit
CDU

7
0

1.81
0

69
2

6.67

311
28

80.36
93.33

<0.0001
fisher:
<0.0001

No
Yes

84
68

7.45
29.31

569
67

50.44
28.88

475
97

42.11
41.81

<0.0001

University
Memorial

77
75

10.43
12.06

319
317

43.22
50.96

342
230

46.34
36.98

0.0023

Male
Female

97
55

11.66
10.48

413
222

49.64
42.29

322
248

38.7
47.24

0.0078

17.83

Abbreviations: CCI - Charlson Comorbidity Index; CDU - Clinical Decision Unit; IVDU - Intravenous Drug Use
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Table 3. Unadjusted
Odds
Ratios
andand
95%95%
Confidence
Table
Unadjustedand
andAdjusted
Adjusted
Odds
Ratios
Confidence Intervals for Patient
Intervals
for Patient Treatment
Sex and Physician
Treatment
Guideline
Adherence
Sex
and Physician
Guideline
Adherence
(Two-Level
Outcome); Cellulitis
(Two-Level
Study,
2017.Outcome); Cellulitis Study, 2017.
Guideline Non-Adherence
Unadjusted
Adjusted *
OR
95% CI
OR
95% CI
Patient Sex
Male
Female

1.00
0.73

Referent
0.59-0.90

1.00
0.75

Referent
0.61-0.94

*Adjusted for CCI Score, Race, IVDU
Abbreviations: CCI - Charlson Comorbidity Index; IVDU - Intravenous Drug Use
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Table 4. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for Sex
and Physician Treatment Guideline Adherence (Three-Level Outcome); Cellulitis Study,
2017.
Table 4. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for Sex and Physician Treatment Guideline Adherence (Three-Level Outcome); Cellulitis Study, 2017.
Guideline Non-Adherence
Undertreated
Overtreated
POR

95% CI

POR

95% CI

Guideline Non-Adherence*
Undertreated
Overtreated
POR

95% CI

POR

95% CI

Guideline Non-Adherence**
Undertreated
Overtreated
POR

95% CI

POR

95% CI

Patient Sex
Male
Female

1.00 Referent
0.80 0.56-1.14

1.00
0.71

Referent
0.57-0.89

1.00
0.89

Referent
0.61-1.29

1.00
0.72

Referent
0.57-0.91

1.00
0.89

Referent
0.61-1.29

1.00
0.72

Referent
0.57-0.92

Physician Sex
Male
Female

1.00
1.06

1.00
1.43

Referent
1.14-1.81

1.00
1.03

Referent
0.70-1.53

1.00
1.48

Referent
1.16-1.88

1.00
1.03

Referent
0.70-1.53

1.00
1.47

Referent
1.16-1.87

Referent
0.73-1.53

p-interaction: 0.80
*Adjusted for age category, CCI score, race, IVDU
**Including physican sex and other covariates from prior model
Abbreviations: CCI - Charlson Comorbidity Index; IVDU - Intravenous Drug Use
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Table 5. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for Sex
and
Physician Treatment Guideline Adherence (Three-Level Outcome) Stratified by
Table 5. Unadjusted and Adjusted Odds Ratios and 95% Confidence Intervals for Sex and Physician Treatment Guideline Adherence (Three-Level
Intervention
Cellulitis
Study,
Outcome) Stratified Status;
by Intervention
Status; Cellulitis
Study, 2017.
2017.
Guideline Non-Adherence
Undertreated
Overtreated
POR

95% CI

POR

95% CI

Guideline Non-Adherence*
Undertreated
Overtreated
POR

95% CI

POR

p-value
95% CI interaction

Physician Sex
0.4
Pre-Intervention
Post-Intervention

Female vs. Male
Female vs. Male

1.27
0.93

0.71-2.26
0.57-1.49

1.77 1.26-2.48
1.24 0.89-1.72

1.08
1.00

0.59-2.01
0.60-1.67

1.79
1.28

1.26-2.55
0.91-1.79

Female vs. Male
Female vs. Male

0.67
1.02

0.42-1.06
0.59-1.78

0.65 0.47-0.90
0.82 0.59-1.13

0.78
1.09

0.48-1.29
0.61-1.94

0.67
0.77

0.48-0.93
0.55-1.08

Patient Sex
0.54
Pre-Intervention
Post-Intervention

*Adjusted for age category, CCI score, race, IVDU
Abbreviations: CCI - Charlson Comorbidity Index; IVDU - Intravenous Drug Use
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Figure 1. Percent of Patients Overtreated by Intervention Status; Cellulitis Study, 2017
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